Tracking the evolution of biomarker efficacy in SARS-CoV-2: a global meta-analyses series
Authors:
Open Access
- 28 April 2026
- journal article
- Published by Springer Nature in Respiratory Research
- Vol. 27 (1)
Abstract
Sophisticated prognostic scores have been proposed for SARS-CoV-2 but do not always perform consistently. We performed this systematic review to discover why and to investigate the impact of vaccination and viral variants. We searched the PubMed database for the keywords ‘SARS-CoV-2’ or ‘Covid19’ with ‘biomarker’ and ‘mortality’ for the baseline tranche (01/12/2019–30/06/2021) and either ‘SARS-CoV-2’ or ‘Covid19’ with ‘biomarker’ and either ‘vaccination’ or ‘variant’ from 01/12/2020 to 31/10/2023. To aggregate the data, the meta library in R was used, and a random effects model fitted to obtain pooled AUCs and 95% confidence intervals. We screened 4,688 potential source manuscripts and included 144 in the final analyses. Biomarker effectiveness varies significantly by geographical region. Admission CRP levels were a good prognostic marker for mortality due to wild-type virus in Asian countries, with a pooled area under curve (AUC) of 0.83 (95%CI 0.80–0.85), but only an average predictor of mortality in Europe/Northern America, with a pooled AUC of 0.67 (95%CI 0.63–0.71, P < 0.0001). The same pattern applies to D-dimer and IL-6. Notably, urea and troponin had pooled AUCs ≥ 0.78 regardless of location, implying that end-organ damage at presentation was a key prognostic factor in wild-type SARS-CoV-2 infection. CRP, D-dimer, and IL-6 have generally declined in effectiveness in the vaccinated and variant cohorts. We note a significant lag from the pandemic advent to data availability and that the type of data varied considerably between studies. Biomarkers and prognostic scores should be tailored to populations. It is imperative that the infrastructure for collecting clinical data should be put in place ahead of a future pandemic so that data harvesting, collation and analysis can occur in a robust and timely manner to aid clinical decision making. This study was registered with PROSPERO (CRD42022366893). The online version contains supplementary material available at 10.1186/s12931-026-03656-9.Keywords
Funding Information
- Medical Research Council (MR/R008051/1)
- Cambridge BHF Centre of Research Excellence (RE/18/1/34212)
- Wellcome Trust ISSF
- British Medical Association (Josephine Lansdell Award)
- Association of Physicians of Great Britain and Ireland (Young Investigator Award)
This publication has 43 references indexed in Scilit:
- Investigation of the relationship between monocyte chemoattractant protein 1 rs1024611 variant and severity of COVID-19Cytokine, 2023
- External validation of the ISARIC 4C Mortality Score to predict in-hospital mortality among patients with COVID-19 in a Canadian intensive care unit: a single-centre historical cohort studyCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2023
- COVID-19 patients’ clinical profile and outcome with respect to their vaccination status: A prospective observational multicentre cohort study during third wave in Western IndiaIndian Journal of Medical Microbiology, 2022
- SARS-CoV-2 Variants Show a Gradual Declining Pathogenicity and Pro-Inflammatory Cytokine Stimulation, an Increasing Antigenic and Anti-Inflammatory Cytokine Induction, and Rising Structural Protein Instability: A Minimal Number Genome-Based ApproachInflammation, 2022
- Laboratory markers of severity across three COVID-19 outbreaks in Australia: has Omicron and vaccinations changed disease presentation?Internal and Emergency Medicine, 2022
- Machine-Learning Model for Mortality Prediction in Patients With Community-Acquired PneumoniaChest, 2022
- Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study)Clinical Microbiology and Infection, 2020
- Clinical Characteristics, Associated Factors, and Predicting COVID-19 Mortality Risk: A Retrospective Study in Wuhan, ChinaAmerican Journal of Preventive Medicine, 2020
- Scoring systems for predicting mortality for severe patients with COVID-19eClinicalMedicine, 2020
- Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in ChinaChest, 2020